Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

News > All

Total search results: 9863 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 43 44 45 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Novartis AG. (1/7/15). "Press Release: Novartis Collaborates with Intellia Therapeutics and Caribou Biosciences to Explore Making Medicines and Drug Discovery Tools with CRISPR Genome Editing technology". Basel. 2015-01-07
Addex Therapeutics S.A.. (1/7/15). "Press Release: Addex and NIAAA Enter Collaboration to Evaluate ADX71441 in Alcohol Use Disorder". Geneva. 2015-01-07
Evotec AG. (1/7/15). "Press Release: Evotec and Padlock Therapeutics Announce Initial Success and Extension of Long-term Collaboration". Hamburg. 2015-01-07
Genkyotex S.A.. (1/7/15). "Press Release: Genkyotex Raises CHF 20 Million ($21 Million)". Geneva & Archamps. 2015-01-07
Provendis GmbH. (1/6/15). "Pressemitteilung: Provendis und TVM Capital Life Science besiegeln strategische Partnerschaft". 2015-01-06
Gilead Sciences, Inc.. (1/6/15). "Press Release: Gilead Sciences Announces Acquisition of Phenex Pharmaceuticals’ Development Program for Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases". Foster City, CA & Ludwigshafen & Heidelberg. 2015-01-06
Cytos Biotechnology AG. (1/6/15). "Press Release: Cytos Exclusively Licenses Its VLP Platform for the Treatment of Hepatitis B Infections to OnCore Biopharma". Schlieren. 2015-01-06
Pfizer Inc.. (1/5/15). "Press Release: Pfizer Acquires Redvax GmbH. Acquisition Provides Pfizer with a Preclinical CMV Vaccine Candidate". 2015-01-05
Bayer AG. (1/5/15). "Press Release: FDA Approves Bayer’s Gadavist (gadobutrol) Injection as the First Magnetic Resonance Contrast Agent for Pediatric Patients Less than 2 Years of Age [Not intended for U.S. and UK Media]". Leverkusen. 2015-01-05
BioMed X GmbH. (1/5/15). "Press Release: Boehringer Ingelheim and BioMed X Collaborate to Discover New Epigenetic Regulators of COPD". Heidelberg. 2015-01-05
Novartis AG. (1/1/15). "Press Release: Novartis Completes Divestment of Animal Health Business to Eli Lilly for USD 5.4 Billion". Basel. 2015-01-01
From »The Analytical Scientist« (Issue 23, December 2014). (12/14). "How to Get PR Right (by Marcus Lippold)". 2014-12-31
Novartis AG. (12/26/14). "Press Release: First in the World Regulatory Approval of Novartis' Cosentyx in Japan for Both Psoriasis and Psoriatic Arthritis". Basel. 2014-12-26
Novartis AG. (12/23/14). "Press Release: Alcon Treatment Travatan Receives EU Approval for Pediatric Glaucoma Patients". Basel. 2014-12-23
Sigma-Aldrich Corporation. (12/23/14). "Press Release: Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance". St. Louis, MO. 2014-12-23
Actelion Ltd.. (12/23/14). "Press Release: Actelion Submits US FDA New Drug Application for Selexipag (Uptravi) in Patients with Pulmonary Arterial Hypertension". Allschwil. 2014-12-23
Pieris Pharmaceuticals, Inc.. (12/23/14). "Press Release: Pieris Pharmaceuticals, Inc. Completes Private Placement, Raises $13.6M". Freising. 2014-12-23
Evotec AG. (12/22/14). "Press Release: Evotec and Ohio State to Collaborate on Novel Cancer Therapy". Hamburg. 2014-12-22
Evolva Holding S.A.. (12/22/14). "Press Release: Evolva Completes Share Sale Related to Allylix acquisition". Reinach. 2014-12-22
Basilea Pharmaceutica Ltd.. (12/22/14). "Press Release: Swissmedic Approves Basilea's Antibiotic Zevtera (ceftobiprole medocaril) for the Treatment of Pneumonia". Basel. 2014-12-22
Sartorius AG. (12/19/14). "Press Release: Sartorius to Sell Its Industrial Technologies Division to Minebea Co., Ltd.". Göttingen. 2014-12-19
Bina Technologies, Inc.. (12/19/14). "Press Release: Bina Technologies Acquired by Roche". Redwood City, CA. 2014-12-19
Markes International Ltd.. (12/19/14). "Press Release: Markes International Further Strengthens Its Product Marketing Expertise with New Appointment". Llantrisant. 2014-12-19
Roche. (12/19/14). "Press Release: Roche Provides Update on Phase III MARIANNE Study in People with Previously Untreated Advanced HER2-positive Breast Cancer". Basel. 2014-12-19
Roche. (12/19/14). "Press Release: Roche Provides Update on Gantenerumab Development Programme". Basel. 2014-12-19
Bruker Corporation. (12/19/14). "Press Release: Announcement of Bruker HMDB Metabolite Library to Accelerate the Accurate Mass Identification of Target Compounds in Clinical Metabolomics". Billerica, MA. 2014-12-19
Analytik Jena AG. (12/19/14). "Press Release: Analytik Jena Announces Group Figures for 2013/2014 Financial Year". Jena. 2014-12-19
MorphoSys AG. (12/19/14). "Press Release: MorphoSys’s Partner Roche Provides Update on Trial of Gantenerumab in Prodromal Alzheimer's Patients". 2014-12-19
Merck & Co., Inc.. (12/18/14). "Press Release: Merck Acquires OncoEthix, a Privately Held Oncology Company Developing Novel BET Inhibitors for Hematological and Solid Cancers". Kenilworth, NJ. 2014-12-18
Sartorius AG. (12/18/14). "Press Release: Sartorius Signs Long-term Syndicated Loan. Credit Volume of 400 Million Euros – International Bank Syndicate Led by BNP Paribas, Commerzbank and LBBW". Göttingen. 2014-12-18
Roche. (12/18/14). "Press Release: Roche Unveils MycoTOOL Real-Time PCR Kit Validation Report for Improved Quality Control of Biopharmaceutical Products". Rotkreuz. 2014-12-18
Roche. (12/18/14). "Press Release: Roche to Acquire Dutalys to Augment Development of Bi-specific Antibodies". Basel. 2014-12-18
Pieris Pharmaceuticals, Inc.. (12/18/14). "Press Release: Pieris Pharmaceuticals, Inc. Goes Public, Raises $12.2 Million. Completion of Alternative Public Offering in Which Pieris AG Becomes a Wholly-Owned Subsidiary of Pieris Pharmaceuticals, Inc.". Fre 2014-12-18
Evotec AG. (12/18/14). "Press Release: Achievement of Multiple Milestones in Evotec’s Drug Discovery Alliances". Hamburg. 2014-12-18
Shimadzu Corporation. (12/18/14). "Press Release: EMC Center Designated as TÜV Rheinland Japan Appointed Laboratory – Aiming to Become an Even More Reliable Testing Laboratory". 2014-12-18
Lonza Group Ltd.. (12/18/14). "Press Release: Lonza and AdAlta Announce a Strain Development Contract for Novel Biologic Therapeutics". Basel & Melbourne. 2014-12-18
Carl Zeiss AG. (12/17/14). "Press Release: Zeiss Asserts Its Position In Difficult Environment. Revenue and Earnings above the Previous Year – Continued High Level of Expenditure on Research and Development". Stuttgart. 2014-12-17
Humedics GmbH. (12/17/14). "Press Release: BioMedInvest-II LP Joins Humedics Series C Financing and Increases Financing Round to 7 Million Euro". Berlin. 2014-12-17
Epigenomics AG. (12/17/14). "Press Release: First Patients Enrolled in Epigenomics’ Epi proColon ADMIT Study". Berlin & Germantown, MD. 2014-12-17
Evolva Holding S.A.. (12/17/14). "Press Release: Evolva Sells EV-035 Series to Emergent BioSolutions". Reinach. 2014-12-17
Addex Therapeutics S.A.. (12/17/14). "Press Release: Addex Amends mGlu2PAM Collaboration Agreement and Receives USD757,000". Geneva. 2014-12-17
Sanofi S.A.. (12/17/14). "Press Release: Merial Acquires Two Major Equine Health Products from Bayer". Paris. 2014-12-17
Varian Medical Systems, Inc.. (12/17/14). "Press Release: Varian Medical Systems Announces Intention to Acquire MeVis Medical Solutions AG through a Public Tender Offer". Palo Alto, CA. 2014-12-17
MeVis Medical Solutions AG. (12/17/14). "Press Release: Executive Board and Supervisory Board welcome public takeover offer of VMS Deutschland Holdings GmbH [Ad hoc announcement]". Bremen. 2014-12-17
Fluidigm Corporation. (12/17/14). "Press Release: Making Single-Cell Biology Work. New Collaboration Between EMBL-EBI, the Wellcome Trust Sanger Institute and Fluidigm Keeps Research and Technology on the Cutting-Edge of Single-Cell Genomics". South San 2014-12-17
H. Lundbeck A/S. (12/17/14). "Press Release: Lundbeck Discontinues Further Development of Desmoteplase, 2014 Profit Guidance Range Narrowed". 2014-12-17
Protagen AG. (12/16/14). "Press Release: Protagen Successfully Closes New Financing Round". 2014-12-16
Sartorius AG. (12/16/14). "Press Release: Sartorius Supervisory Board Extends Appointment of the Group’s CEO Joachim Kreuzburg". Göttingen. 2014-12-16
Roche. (12/16/14). "Press Release: Roche Launches PCR Molecular Diagnostic System for Point of Care Environment". Pleasanton, CA. 2014-12-16
Evolva Holding S.A.. (12/16/14). "Press Release: Evolva Completes Allylix Acquisition". Reinach. 2014-12-16
Novartis AG. (12/16/14). "Press Release: Novartis Gains FDA Approval for Signifor LAR to Treat Patients with Acromegaly, a Rare and Life-threatening Hormonal Disorder". Basel. 2014-12-16
MorphoSys AG. (12/15/14). "Press Release: MorphoSys's MOR208 Program Receives Positive Opinion for Orphan Medicinal Product Designation from EMA for DLBCL". 2014-12-15
Roche. (12/15/14). "Press Release: Roche Expands CE-IVD Claims for Organ and Tissue Testing for Next Generation Blood Screening Assays". Pleasanton, CA. 2014-12-15
Boehringer Ingelheim. (12/15/14). "Press Release: First Trial of a Novel Oral Anticoagulant Starts in Prevention of Recurrent Stroke Due to a Blood Clot of Undetermined Source [For Non-US/Non-UK/Non-Canadian Media]". Ingelheim. 2014-12-15
Annexon Biosciences. (12/15/14). "Press Release: Annexon Bioscience Closes $34M Series". Redwood City, CA. 2014-12-15
Sygnis AG. (12/12/14). "Press Release: Sygnis AG Successfully Completes Rights Offering and Private Placement". Heidelberg. 2014-12-12
Deutsche Biotech Innovativ AG. (12/12/14). "Pressemitteilung: Kapitalerhöhung beschlossen und bereits erfolgreich platziert". Hennigsdorf. 2014-12-12
Roche. (12/12/14). "Press Release: Changes in Roche Board of Directors and Enlarged Corporate Executive Committee". Basel. 2014-12-12
Dentons. (12/12/14). "Press Release: Dentons Enhances German Compliance Offering with Two New Hires". Basel. 2014-12-12
Pieris AG. (12/11/14). "Press Release: Pieris Initiates Phase I Clinical Trial for Anticalin to Treat Anemia". Freising. 2014-12-11
BioRN Cluster Management GmbH. (12/11/14). "Press Release: Biotech-Cluster Rhine-Neckar (BioRN) Leads InnoLife Consortium to Success in the Competition Healthy Living and Active Ageing of the European Institute for Innovation and Technology (EIT)". Heide 2014-12-11
Anergis S.A.. (12/11/14). "Press Release: Anergis Starts Phase II Dose Ranging Trial with Birch Pollen Allergy Vaccine AllerT. Dose Assessment for Upcoming Phase III Trial". Epalinges. 2014-12-11
Evolva Holding S.A.. (12/11/14). "Press Release: Evolva Announces Multi-product Collaboration with Takasago". Reinach. 2014-12-11
Danaher Corporation. (12/11/14). "Press Release: Danaher Completes Acquisition Of Nobel Biocare". Washington, D.C.. 2014-12-11
CovalX AG. (12/11/14). "Press Release: CovalX HM3 in Shimadzu Demo Laboratory in Kyoto, Japan". 2014-12-11
Noxxon Pharma AG. (12/10/14). "Press Release: New Addition to Noxxon Supervisory Board Brings Significant US Public Market Expertise. Don deBethizy Joins Noxxon Supervisory Board". Berlin & Boston, MA. 2014-12-10
Roche. (12/10/14). "Press Release: Roche Diagnostics Purchases Tissue Dissection Technology from AvanSci Bio". Pleasanton, CA. 2014-12-10
BioRegio STERN Management GmbH. (12/10/14). "Press Release: Newly Established CeMeT GmbH in Tübingen Analysing the Metagenome of Microorganisms in the Human Body". 2014-12-10
Roche. (12/10/14). "Press Release: Roche’s Preeclampsia Test Helps to Predict this Life-threatening Condition in Pregnant Women at Risk. New Data Demonstrate High Prognostic Value of Elecsys Blood Test". Basel. 2014-12-10
Lonza Group Ltd.. (12/10/14). "Press Release: Lonza Executes Collaboration Agreements with Two Innovation Clusters". Basel. 2014-12-10
Selexis S.A.. (12/9/14). "Press Release: Symphogen A/S Licenses the Selexis SUREtechnology Expression Platform and Cell Line". Geneva. 2014-12-09
Heraeus Medical GmbH. (12/9/14). "Press Release: Heraeus Medical GmbH Signs Exclusive License and Development Agreement with Locate Therapeutics for Orthopaedic Applications". 2014-12-09
4SC AG. (12/9/14). "Press Release: 4SC Reports Positive Topline Data from Clinical Phase I Trial with 4SC-205 in Cancer Patients Using Novel Continuous Dosing Scheme". Planegg-Martinsried. 2014-12-09
Bayer AG. (12/9/14). "Press Release: Bayer and DNDi Sign First Agreement to Develop an Innovative Oral Treatment for Human River Blindness". Berlin & Geneva. 2014-12-09
Sygnis AG. (12/8/14). "Press Release: Sygnis AG Signs Initial Non-exclusive Distribution Agreement for Its First Proprietary Product with BioCat GmbH. TruePrime Single Cell WGA Kit to Be Launched early 2015". Madrid & Heidelberg. 2014-12-08
Definiens AG. (12/8/14). "Press Release: Definiens Releases Tissue Studio 4.0 for Quantitative Digital Pathology". Munich. 2014-12-08
Epigenomics AG. (12/8/14). "Press Release: Epigenomics and BioChain Announce Approval of Epi proColon in China". Berlin et al.. 2014-12-08
Carl Zeiss Meditec AG. (12/8/14). "Press Release: Annual Statement – Carl Zeiss Meditec Posts Slight Revenue Growth. Currency Effects and Regional Variations in Business Burden Results". Jena. 2014-12-08
Affimed N.V.. (12/8/14). "Press Release: Affimed Presents Final Data for AFM13 Phase 1 Trial at ASH. Data Confirm Clinical Activity in Relapsed/Refractory Hodgkin Lymphoma Patients". Heidelberg. 2014-12-08
MorphoSys AG. (12/8/14). "Press Release: MorphoSys Presents Updated Phase 2 Clinical Results for MOR208 Monotherapy in NHL at American Society of Hematology Meeting. DLBCL and FL Identified as Particularly Promising Indications". 2014-12-08
Pieris AG. (12/8/14). "Press Release: Pieris Achieves GLP Tox Milestone Payment in Daiichi Sankyo Collaboration to Develop Anticalin Therapeutics". Freising. 2014-12-08
Roche. (12/8/14). "Press Release: Roche Launches Next-generation Viral Load Testing Assays for New Molecular Diagnostic Platforms in Markets Accepting the CE Mark". Basel. 2014-12-08
Proteo Biotech AG. (12/5/14). "Press Release: Proteo Biotech AG Expands Management Board". Irvine, CA & Kiel. 2014-12-05
Sigma-Aldrich Corporation. (12/5/14). "Press Release: Sigma-Aldrich Stockholders Approve Acquisition By Merck KGaA". St. Louis, MO. 2014-12-05
Metabolomic Discoveries GmbH. (12/5/14). "Press Release: KWS and Metabolomic Discoveries Sign Research Agreement". Einbeck & Potsdam. 2014-12-05
Roche. (12/5/14). "Press Release: Roche to Present Clinical Data from Six Different Medicines at ASH". Basel. 2014-12-05
Basilea Pharmaceutica Ltd.. (12/5/14). "Press Release: Basilea Announces Launch of Antibiotic Zevtera® (ceftobiprole medocaril) in Germany. First Commercial Launch". Basel. 2014-12-05
Molecular Partners AG. (12/5/14). "Press Release: Total Offer Size of IPO Reaches CHF 106.2 Million after Partial Exercise of IPO Over-allotment Option". Zürich-Schlieren. 2014-12-05
Sigma-Aldrich Corporation. (12/4/14). "Press Release: Sigma-Aldrich Life Sciences Licenses Foundational CRISPR Patents from Broad Institute". St. Louis, MO. 2014-12-04
Qiagen N.V.. (12/4/14). "Press Release: Qiagen to Distribute Altona Diagnostic’s RealStar Ebolavirus RT-PCR Kit 1.0, Recently Authorized by the FDA for Emergency Use". Hilden & Germantown, MD. 2014-12-04
Ionicon Analytik GmbH. (12/4/14). "Press Release: Fast GC Add-on for Ionicon PTR-TOF Instruments. Gas Chromatographic Separation Now Combined with Real-time Trace Gas Analysis". Innsbruck. 2014-12-04
Anergis S.A.. (12/3/14). "Press Release: Anergis Closes Series B Financing Round Totaling CHF 14.5 Million". Epalinges. 2014-12-03
Sigma-Aldrich Corporation. (12/3/14). "Press Release: Sigma-Aldrich Launches Comprehensive Flavors and Fragrances Standards Portfolio Aimed at Food & Beverage and Cosmetics Industries". St. Louis, MO. 2014-12-03
Amgen Inc.. (12/3/14). "Press Release: FDA Approves Blincyto (blinatumomab) Immunotherapy for the Treatment of Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia". Thousand Oaks, CA & South San Francisco, CA. 2014-12-03
GATC Biotech AG. (12/3/14). "Press Release: GATC Biotech Lifts Next Generation Sequencing Services with NGSelect to the Next Level. Customers Benefit from a Modular Set-up Which Meets Frequent Scientific Needs". Constance. 2014-12-03
VTU Technology GmbH. (12/3/14). "Press Release: VTU Technology and RCT Announce Partnership". Tucson, AZ & Grambach. 2014-12-03
Actelion Ltd.. (12/2/14). "Press Release: Actelion Submits Selexipag (Uptravi) for EMA Marketing Authorisation in Patients with Pulmonary Arterial Hypertension". Allschwil. 2014-12-02
Roche. (12/2/14). "Press Release: Roche Acquires Ariosa Diagnostics and Enters the Non-invasive Prenatal Test (NIPT) and Cell-free DNA Testing Services Markets". Basel. 2014-12-02
High-Tech Gründerfonds Management GmbH. (12/2/14). "Press Release: HTGF Portfolio Company Ayoxxa Biosystems Extends Series B. Andreas Richter New CFO of Ayoxxa". Cologne & Bonn. 2014-12-02
Enamine Ltd.. (12/2/14). "Press Release: BioVersys and Enamine Announce Extension of Drug Discovery Collaboration to Address Multidrug-Resistant Bacterial Infections". Kiev & Basel. 2014-12-02
next pagenext page 1 2 3 ... 43 44 45 ... 97 98 99  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top